NeoGenomics (NGNM) Reports Q3 Results, Positive Outlook
NeoGenomics Inc., a provider of cancer-focused genetic testing services, today posted its third-quarter results for the three months ended September 30, 2010. Revenue for the third quarter was reported at $8.7 million, a 19 percent increase over the $7.3 million reported in the third quarter 2009. The company increased its sales and marketing expenses by 11 percent over the third quarter of last year, spending approximately $190,000 on increases in sales and recruiting staff. General and administrative expenses increased 19 percent. The company attributes the increase primarily as a result of additional information technology personnel, R&D activities, and to approximately…